Cargando…
Clinical impact of (99m)Tc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients
BACKGROUND: Recent data demonstrated that personalized dosimetry-based selective internal radiotherapy (SIRT) is associated with better outcome for unresectable hepatocellular carcinoma (HCC). AIM: We aim to evaluate the contribution of personalized predictive dosimetry (performed with Simplicity(90...
Autores principales: | Bucalau, Ana-Maria, Collette, Benoît, Tancredi, Illario, Vouche, Michael, Pezzullo, Martina, Bouziotis, Jason, Moreno-Reyes, Rodrigo, Trotta, Nicola, Levillain, Hugo, Van Laethem, Jean Luc, Verset, Gontran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326228/ https://www.ncbi.nlm.nih.gov/pubmed/37414964 http://dx.doi.org/10.1186/s41824-023-00171-8 |
Ejemplares similares
-
Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes
por: Bucalau, Ana-Maria, et al.
Publicado: (2020) -
In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
por: Bucalau, Ana-Maria, et al.
Publicado: (2021) -
Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2020) -
Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization
por: Deforche, Maxime, et al.
Publicado: (2022) -
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2021)